Insilico Medicine leadership team shares insights on AI-powered healthcare innovation

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 24 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 51%
  • Publisher: 71%

Medicine News

Aging,Artificial Intelligence,Cancer

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announces that the co-CEOs of the company – Alex Zhavoronkov, PhD, and Feng Ren, PhD – will be attending the 15th Annual Meeting of the New Champions, also known as Summer Davos hosted by the World Economic Forum, in Dalian,...

InSilico MedicineJun 21 2024 Insilico Medicine , a clinical-stage generative artificial intelligence -driven drug discovery company, announces that the co-CEOs of the company – Alex Zhavoronkov, PhD, and Feng Ren, PhD – will be attending the 15th Annual Meeting of the New Champions, also known as Summer Davos hosted by the World Economic Forum, in Dalian, China, from 25 to 27 June 2024.

During the meeting, Alex Zhavoronkov, PhD, founder and CEO of Insilico was invited to speak at the session "Can Appetite Control Lead to Healthier Humans?" on 10:00-10:30 a.m., June 27, 2024. According to World Health Organization data, overweight and obesity impact 43% and 16% of adults, respectively, rising as a global health issue demanding immediate intervention, and novel drugs could be the new hope for a healthier future with stricter diets.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO ConventionLeadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ('Insilico') will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.
Source: NewsMedical - 🏆 19. / 71 Read more »